MassDevice Earnings Roundup
Haemonetics ends its fiscal year in Q4 red
Haemonetics (NYSE:HAE) finished out its 2015 fiscal 4th quarter in the red, hammered by a U.S. market shift that affected its blood center business, uncertainty in Russia, currency fluctuations and restructuring.